Skip to main content

Table 3 Comparison of GSS symptoms and serological status

From: Abdominal symptoms during Sjogren’s syndrome: a pilot study

 

SSA+ (n = 80)

SSA- (n = 70)

Total (n = 150)

p-value a

n (%) or mean (sd)

Upper abdominal symptoms

63 (78.8)

67 (97.1)

131 (87.3)

0.0008

Upper abdominal pain

31 (38.7)

52 (75.4)

84 (56.0)

< 0.0001

Abdominal discomfort

40 (50.0)

47 (68.1)

88 (58.7)

0.0253

Bloating

50 (62.5)

54 (78.3)

105 (70.0)

0.0367

Nausea

25 (31.2)

35 (50.7)

60 (40.0)

0.0157

Vomiting

10 (12.5)

11 (15.9)

21 (14.0)

n.s.

Lower abdominal symptoms

63 (78.8)

59 (85.5)

123 (82.0)

n.s.

Lower abdominal pain

35 (43.7)

39 (56.5)

75 (50.0)

n.s.

Diarrhea

21 (26.2)

35 (50.7)

56 (37.3)

0.0021

Tenesmus

14 (17.5)

13 (18.8)

28 (18.7)

n.s.

Constipation

42 (52.5)

40 (58.0)

82 (54.7)

n.s.

Dysuria

10 (12.5)

19 (27.5)

29 (19.3)

0.0208

  1. sd standard deviation, GSS global symptoms score, n.s not significant
  2. aFor quantitative variables in a normal distribution, the Student’s t-test was used to compare groups of two or more classes; for variables that do not follow a normal distribution, the Wilcoxon signed-rank test or the Kruskal-Wallis test was used to compare groups of two or more classes. The value p < 0.05 was considered significant